CynergisTek Inc (NYSEAMERICAN:CTEK) CEO William Caleb Barlow bought 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 11th. The stock was acquired at an average cost of $2.85 per share, for a total transaction of $28,500.00.

CynergisTek stock opened at $2.97 on Thursday. CynergisTek Inc has a fifty-two week low of $2.75 and a fifty-two week high of $5.00.

CynergisTek (NYSEAMERICAN:CTEK) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($0.05) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.07) by $0.02. The firm had revenue of $5.06 million for the quarter, compared to the consensus estimate of $5.80 million.

Institutional investors have recently bought and sold shares of the business. Morgan Stanley lifted its holdings in shares of CynergisTek by 208.0% during the second quarter. Morgan Stanley now owns 5,135 shares of the company’s stock valued at $25,000 after purchasing an additional 3,468 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of CynergisTek by 21.0% during the second quarter. BlackRock Inc. now owns 27,501 shares of the company’s stock valued at $133,000 after purchasing an additional 4,771 shares during the last quarter. Globeflex Capital L P lifted its holdings in shares of CynergisTek by 18.5% during the first quarter. Globeflex Capital L P now owns 83,282 shares of the company’s stock valued at $414,000 after purchasing an additional 12,982 shares during the last quarter. King Luther Capital Management Corp lifted its holdings in shares of CynergisTek by 11.3% during the first quarter. King Luther Capital Management Corp now owns 197,500 shares of the company’s stock valued at $982,000 after purchasing an additional 20,000 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of CynergisTek by 69.9% during the second quarter. Renaissance Technologies LLC now owns 107,983 shares of the company’s stock valued at $523,000 after purchasing an additional 44,441 shares during the last quarter.

Several research firms have weighed in on CTEK. Zacks Investment Research raised CynergisTek from a “sell” rating to a “hold” rating in a research report on Tuesday, June 4th. B. Riley set a $7.00 price objective on CynergisTek and gave the company a “buy” rating in a research report on Friday, August 16th.

About CynergisTek

Cynergistek, Inc provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program.

Further Reading: What does a bar chart display?

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with MarketBeat.com's FREE daily email newsletter.